Drug Type Small molecule drug |
Synonyms AntimicroRNA-19 |
Target |
Action inhibitors |
Mechanism MicroRNAs inhibitors, Epigenetic drug |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Atherosclerosis | Preclinical | - | - | |
| Atherosclerosis | Preclinical | - | - | |
| Metabolic Diseases | Preclinical | - | - | |
| Metabolic Diseases | Preclinical | - | - |





